The US Food and Drug Administration’s biologics center is looking for a leader of its rare disease efforts, another indicator of the sector’s growing impact on biologics, as well as drug development.
Key Takeaways
-
CBER is hiring an associate director for rare diseases and special populations to lead rare disease and other initiatives.
-
The position was created to expand a role that had been in charge of leading clinical issues in the center, which recently became vacant
The Center for Biologics Evaluation and Research is looking for an associate director for rare diseases and special populations to lead “development, implementation, execution, management and direction” of its rare disease program and other initiatives “related to advancing the development of CBER-regulated products for diseases and conditions that are rare and affect other special populations, such as pediatric populations,” according to the
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?
